Mathew V, Olson L J, Gertz M A, Hayes D L
Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Am J Cardiol. 1997 Dec 1;80(11):1491-2. doi: 10.1016/s0002-9149(97)82785-3.
Symptomatic conduction system disease in cardiac amyloidosis and its management has been reported infrequently. We report our experience of patients with amyloidosis having symptomatic conduction system disease requiring permanent pacemaker implantation.
心脏淀粉样变性中症状性传导系统疾病及其治疗的报道较少。我们报告了淀粉样变性患者出现需要植入永久性起搏器的症状性传导系统疾病的经验。
